Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Amin

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Science (New York, N.Y.)|July 20, 1973
Methylmercury poisoning in IraqF Bakir, S F Damluji, L Amin-Zaki, et al.
Annals of Surgical Oncology|July 11, 2018
Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-InterventionsLyndsey J Kilgore, Sabrina S Korentager, Amanda N Hangge, et al.
NPJ Breast Cancer|June 25, 2026
Prognostic consistency of oncotype DX® molecular assay across racial groups in early-stage hormone receptor-positive breast cancerReine Abou Zeidane, Benjamin Hauk, Samuel Lichtman-Mikol, et al.
Mucosal Immunology|January 5, 2017
Cadherin 26 is an alpha integrin-binding epithelial receptor regulated during allergic inflammationJ M Caldwell, M H Collins, K A Kemme, et al.
JCO Precision Oncology|April 9, 2026
Prognostic Value of MammaPrint in Diverse Populations: Evaluating Racial Disparities in Breast Cancer OutcomesReine Abou Zeidane, Samuel Lichtman-Mikol, Courtney Pisano, et al.
JAMA Surgery|October 23, 2023
Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical TrialSeema A Khan, Xinlei Mi, Yanfei Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2020
Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP)Priyanka Sharma, Bruce F Kimler, Anne O'Dea, et al.
The Journal of Pathology|October 29, 2021
Mouse-INtraDuctal (MIND): an in vivo model for studying the underlying mechanisms of DCIS malignancyYan Hong, Darlene Limback, Hanan S Elsarraj, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2018
Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus DocetaxelPriyanka Sharma, Sara López-Tarruella, José Angel García-Saenz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2016
Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two CohortsPriyanka Sharma, Sara López-Tarruella, Jose Angel García-Saenz, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Science (New York, N.Y.)|July 20, 1973
Methylmercury poisoning in IraqF Bakir, S F Damluji, L Amin-Zaki, et al.
Annals of Surgical Oncology|July 11, 2018
Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-InterventionsLyndsey J Kilgore, Sabrina S Korentager, Amanda N Hangge, et al.
NPJ Breast Cancer|June 25, 2026
Prognostic consistency of oncotype DX® molecular assay across racial groups in early-stage hormone receptor-positive breast cancerReine Abou Zeidane, Benjamin Hauk, Samuel Lichtman-Mikol, et al.
Mucosal Immunology|January 5, 2017
Cadherin 26 is an alpha integrin-binding epithelial receptor regulated during allergic inflammationJ M Caldwell, M H Collins, K A Kemme, et al.
JCO Precision Oncology|April 9, 2026
Prognostic Value of MammaPrint in Diverse Populations: Evaluating Racial Disparities in Breast Cancer OutcomesReine Abou Zeidane, Samuel Lichtman-Mikol, Courtney Pisano, et al.
JAMA Surgery|October 23, 2023
Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical TrialSeema A Khan, Xinlei Mi, Yanfei Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2020
Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP)Priyanka Sharma, Bruce F Kimler, Anne O'Dea, et al.
The Journal of Pathology|October 29, 2021
Mouse-INtraDuctal (MIND): an in vivo model for studying the underlying mechanisms of DCIS malignancyYan Hong, Darlene Limback, Hanan S Elsarraj, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2018
Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus DocetaxelPriyanka Sharma, Sara López-Tarruella, José Angel García-Saenz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2016
Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two CohortsPriyanka Sharma, Sara López-Tarruella, Jose Angel García-Saenz, et al.
Pageof 10